Jonathan Graham - Amgen Senior Vice President General Counsel, Secretary
| AMGN Stock | MXN 5,785 6.00 0.10% |
President
Mr. Jonathan P. Graham is the Senior Vice President, General Counsel, Secretary of Amgen Inc. Prior to joining the Company, From July 2006 to May 2015, Mr. Graham was Senior Vice President and General Counsel at Danaher Corporationrationration. From October 2004 to June 2006, Mr. Graham was Vice President, Litigation and Legal Policy at General Electric Company . Prior to GE, Mr. Graham was a partner at Williams Connolly LLP. since 2015.
| Age | 62 |
| Tenure | 9 years |
| Phone | 805 447 1000 |
| Web | https://www.amgen.com |
Amgen Management Efficiency
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| John Rex | UnitedHealth Group Incorporated | 61 | |
| David Wichmann | UnitedHealth Group Incorporated | 56 | |
| Hans Vestberg | Verizon Communications | 58 | |
| Michael Wassmer | Capital One Financial | 53 | |
| Steven Sear | Delta Air Lines | 53 | |
| Matthew Ellis | Verizon Communications | 52 | |
| Wayne West | Delta Air Lines | 58 | |
| Rahul Samant | Delta Air Lines | 56 | |
| Thomas Roos | UnitedHealth Group Incorporated | 50 | |
| Marianne Short | UnitedHealth Group Incorporated | 68 | |
| Joanne Smith | Delta Air Lines | 60 | |
| Sanjiv Yajnik | Capital One Financial | 66 | |
| James Clark | CVS Health | 58 | |
| Brady Connor | Verizon Communications | N/A | |
| Paul Jacobson | Delta Air Lines | 47 | |
| Peter Carter | Delta Air Lines | 59 | |
Management Performance
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Linda Louie, VP Officer | ||
| Robert Bradway, Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee | ||
| Murdo Gordon, Executive Vice President of Global Commercial Operations | ||
| Peter Griffith, Ex CFO | ||
| Esteban Santos, Executive Vice President Operations | ||
| Jonathan Graham, Senior Vice President General Counsel, Secretary | ||
| Nancy Grygiel, Sr Officer | ||
| Mike Zahigian, VP Officer | ||
| David MD, Ex RD | ||
| Arvind Sood, IR Contact Officer |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 3.36 T | |||
| Shares Outstanding | 533.98 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 80.38 % | |||
| Price To Earning | 267.53 X | |||
| Price To Book | 40.33 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.